TickerFactsScreenerDevelopers

EUPRAXIA PHARMACEUTICALS INC. (EPRX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$14.40M2023: -$20.75M2024: -$29.99M2025: -$28.55M-$28.55M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$28.55M+4.8%
2024-$29.99M-44.6%
2023-$20.75M-44.1%
2022-$14.40M—